查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601597

封閉式藥物移附註設備 (CSTD) 的全球市場:類型·零組件·封閉機制·技術·不同地區的預測 (～2032年)

Global Closed System Drug Transfer Device Market Research Report Information By type, By Component, By Closing Mechanism, By Technology By Region- Forecast to 2032
出版日期: | 出版商: Market Research Future | 英文 146 Pages | 訂單完成後即時交付

價格

封閉式藥物轉移裝置 (CSTD) 市場規模預計將從 2023 年的 10.7 億美元增長到 2024 年的 12 億美元，預測期內複合年增長率為 10.17%，到 2032 年預計將增長到28.7億美元。醫療保健行業的嚴格監管和全球癌症發病率的上升正在推動市場發展。

全球癌症發生率不斷上升正在推動全球封閉式藥物轉移裝置 (CSTD) 市場的發展。這是因為癌症治療通常需要使用危險藥物，這可能會危及治療患者的醫護人員的健康。使用密封防漏機制可防止這些危險物質釋放到環境中。

地理洞察

北美地區將在 2023 年佔據最大的市場佔有率，預計到 2032 年將達到 99.2 億美元，預測期內複合年增長率為 9.10%。

預計北美地區所佔佔有率最大，為 38.14%。強大的研發基礎設施和不斷增加的癌症患者數量是這一巨大佔有率背後的主要因素。 2020 年，美國報告了 1,603,844 例新癌症病例和 602,347 例癌症死亡病例。

亞太地區預計將出現顯著增長，並且預計在預測期內增長最快。這是由於大量的區域參與者和較小的進入者正在努力獲得市場佔有率。

本報告提供全球封閉式藥物移附註設備 (CSTD) 的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

  • 促進因素
    • 全球癌症發生率不斷上升
    • 醫療保健產業的嚴格監管要求
  • 阻礙因素
    • 與 CSTD 相關的高成本
  • 機會
    • 封閉式 CSTD 中技術進步的發展）

第5章 市場要素分析

  • 波特的五力分析
  • COVID-19對全球CSTD市場帶來的影響

第6章 全球封閉式藥物移附註設備 (CSTD) 市場:各類型

  • 薄膜對薄膜系統
  • 針頭無系統

第7章 全球封閉式藥物移附註設備 (CSTD) 市場:各零件

  • 注射器安全設備
  • 管瓶存取(點閱)設備
  • 飾品
  • 袋子/線存取(點閱)設備

第8章 全球封閉式藥物移附註設備 (CSTD) 市場:封閉機制

  • 推轉系統
  • 顏色到顏色對齊系統
  • LEUR鎖定系統
  • 點選鎖定

第9章 全球封閉式藥物移附註設備 (CSTD) 市場:各技術

  • 火車包廂化設備
  • 隔膜為基礎的設備
  • 空氣過濾設備

第10章 全球封閉式藥物移附註設備 (CSTD) 市場:各終端用戶

  • 醫院·診所
  • 專門中心
  • 其他

第11章 全球封閉式藥物移附註設備 (CSTD) 市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 其他地區
    • 中東
    • 非洲
    • 南美

第12章 競爭情形

  • 市場佔有率分析
  • 競爭儀表板
  • 上市公司的股票概要
  • 比較分析:主要企業的財務
  • 主要的展開·成長策略

第13章 企業簡介

  • B. BRAUN SE
  • JMS CO.LTD.
  • ICU MEDICAL, INC.
  • SIMPLIVIA
  • EQUASHIELD
  • BD
  • BAXTER
  • CORMED
  • YUKON MEDICAL
  • CARAGEN LTD

第14章 資料的引用

Product Code: MRFR/HC/6264-CR

Global Closed System Drug Transfer Device Market Research Report Information By type (Membrane to Membrane and Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, and Air Filtration Devices) By Region- Forecast to 2032

Market Profile

The Closed System Drug Transfer Device Market is expected to have value USD 1.07 billion in 2023. From USD 1.20 billion in 2024 to USD 2.87 billion by 2032 the sector is expected to have a compound annual growth rate (CAGR) of 10.17%. The rigorous regulations of the healthcare industry and the worldwide increasing frequency of cancer are driving development in the market.

Importantly, the growing worldwide cancer prevalence is driving the global closed-system drug transfer device (CSTD) market. This is so because cancer therapy usually requires the use of dangerous drugs that could compromise the health of medical professionals handling them. By use of a closed and leak-proof mechanism, the device is meant to stop the release of these dangerous drugs into the surroundings. Furthermore driving the rising global cancer burden include environmental causes, aging population, better diagnosis tools, and lifestyle choices promoting market expansion.

Segregation of the market

Based on type, the worldwide closed-system drug transfer device market is divided into superfluous systems and membrane-to- membrane systems.

Four categories have been established out of the market: vial access devices, hypodermic safety devices, bag/line access devices, and accessories. The component grounds this division.

Four markets have been developed out of the market: push-to--turn systems, color-to--color alignment systems, leur lock systems, and click-to-lock systems. The closure mechanism forms basis for this classification.

Based on technology, the Closed System Drug Transfer Device Market now consists of air filtration devices, diaphragm-based devices, and compartmentalized devices.

The Market has been segmented into hospitals & clinics, specialty centers, and others based on the end consumer.

Geographic Insights

The Closed System Drug Transfer Device Market has been segmented into the Rest of the World, Asia-Pacific, Europe, and North America based on region. It is anticipated that North America will account for the largest market share in 2023 and reach USD 9.92 billion by 2032, with a compound annual growth rate (CAGR) of 9.10% during the forecast period.

The global CSTD market is expected to be dominated by North America, which holds the largest market share of 38.14%. The strong research and development infrastructure and the increasing prevalence of cancer cases are the primary factors contributing to this substantial market share. For example, in 2020, the United States reported 1,603,844 new cancer cases and 602,347 cancer fatalities.

Asia-Pacific is anticipated to experience substantial growth and is anticipated to be the fastest-growing region during the forecast period. This is attributed to the growing number of new vendors involved in the drug-device system, as numerous regional and small market participants are attempting to leverage their market share.

The Closed System Drug Transfer Device Market is distinguished by the presence of numerous global, regional, and local vendors. The market is intensely competitive, with all participants striving to acquire the largest possible market share. Market growth is significantly influenced by intense competition, frequent changes in government policies, and regulations.

Major Players

Becton, Dickson, and Company, Inc., Baxter International Inc., ICU Medical, Inc., JMS Co.Ltd, B. Braun SE, Simplivia (Israel), Becton, Cormed (US), Yukon Medical (US), Caragen Ltd. (Ireland), and Equashield are among the major players in the Closed System Drug Transfer Device Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4. MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF CANCER ACROSS THE GLOBE
    • 4.2.2 STRINGENT REGULATORY REQUIREMENTS WITHIN THE HEALTHCARE INDUSTRY
  • 4.3 RESTRAINTS
    • 4.3.1.HIGH COST ASSOCIATED WITH CSTD
  • 4.4 OPPORTUNITY
    • 4.4.1.GROWING TECHNOLOGICAL ADVANCEMENTS IN CLOSED SYSTEM DRUG TRANSFER DEVICES (CSTDS)

5.MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2.BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET

6.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 MEMBRANE-TO-MEMBRANE SYSTEMS
  • 6.3.NEEDLELESS SYSTEM

7.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
  • 7.2 SYRINGE SAFETY DEVICE
  • 7.3 VIAL ACCESS DEVICES
  • 7.4.ACCESSORIES
  • 7.5 BAG/LINE ACCESS DEVICES

8.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM

  • 8.1 INTRODUCTION
  • 8.2 PUSH TO TURN SYSTEM
  • 8.3 COLOR-TO-COLOR ALIGNMENT SYSTEM
  • 8.4 LEUR LOCK SYSTEMS
  • 8.5.CLICK-TO-LOCK

9.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
  • 9.2 COMPARTMENTALIZE DEVICES
  • 9.3 DIAPHRAGM-BASED DEVICES
  • 9.4 AIR FILTRATION DEVICES

10.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & CLINICS
  • 10.3 SPECIALTY CENTERS
  • 10.4 OTHERS

11.GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 INDIA
    • 11.4.3 JAPAN
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST
    • 11.5.2 AFRICA
    • 11.5.3 LATIN AMERICA

12.COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET SHARE ANALYSIS,
  • 12.3 COMPETITOR DASHBOARD
  • 12.4 PUBLIC PLAYERS STOCK SUMMARY
  • 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 PRODUCT LAUNCH
    • 12.6.2 PRODUCT APPROVAL

13.COMPANY PROFILES

  • 13.1 B. BRAUN SE
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 PRODUCTS OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 JMS CO.LTD.
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 PRODUCTS OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 KEY STRATEGIES
  • 13.3 ICU MEDICAL, INC.
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 PRODUCT OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 SWOT ANALYSIS
    • 13.3.6 KEY STRATEGIES
  • 13.4 SIMPLIVIA
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 PRODUCTS OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 KEY STRATEGIES
  • 13.5 EQUASHIELD
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 PRODUCTS OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 KEY STRATEGIES
  • 13.6 BD
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 PRODUCTS OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 SWOT ANALYSIS
    • 13.6.6 KEY STRATEGIES
  • 13.7 BAXTER
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 PRODUCTS OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY STRATEGIES
  • 13.8 CORMED
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 PRODUCTS OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 KEY STRATEGIES
  • 13.9 YUKON MEDICAL
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 PRODUCTS OFFERED
    • 13.9.4 KEY DEVELOPMENTS
    • 13.9.5 SWOT ANALYSIS
    • 13.9.6 KEY STRATEGIES
  • 13.13.CARAGEN LTD
    • 13.13.1 COMPANY OVERVIEW
    • 13.13.2 FINANCIAL OVERVIEW
    • 13.13.3 PRODUCTS OFFERED
    • 13.13.4 KEY DEVELOPMENTS
    • 13.13.5 KEY STRATEGIES

14 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR MEMBRANE-TO-MEMBRANE SYSTEMS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR NEEDLELESS SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR SYRINGE SAFETY DEVICE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR VIAL ACCESS DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR ACCESSORIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR BAG/LINE ACCESS DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR PUSH TO TURN SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR COLOR-TO-COLOR ALIGNMENT SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR LEUR LOCK SYSTEMS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR CLICK-TO-LOCK, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR COMPARTMENTALIZE DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR DIAPHRAGM-BASED DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR AIR FILTRATION DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR SPECIALTY CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 26 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 27 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 28 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 30 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 31 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 32 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 33 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 34 US: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 35 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 36 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 37 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 38 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 39 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 40 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 41 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 42 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 43 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 44 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 45 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 46 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 47 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 48 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 49 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 50 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 51 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 52 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 53 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 54 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 55 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 56 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 57 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 58 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 59 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 60 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 61 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 62 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 63 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 64 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 65 UK: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 66 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 67 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 68 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 69 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 70 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 71 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 72 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 73 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 74 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 75 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 76 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 77 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 78 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 79 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 80 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 87 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 88 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 89 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 90 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 91 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 92 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 93 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 94 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 95 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 96 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 97 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 98 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 99 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 100 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 101 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 102 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 103 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 104 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 105 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 106 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 107 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 108 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 109 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 110 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 111 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 112 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 113 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 114 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 115 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 116 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 117 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 118 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 119 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 120 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 121 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 122 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 123 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 124 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 125 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 126 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 127 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 128 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 129 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 130 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 131 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 132 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 133 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 134 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2032 (USD MILLION)
  • TABLE 135 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2032 (USD MILLION)
  • TABLE 136 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION)
  • TABLE 137 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 138 PRODUCT LAUNCH
  • TABLE 139 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 140 JMS CO.LTD.: PRODUCTS OFFERED
  • TABLE 141 ICU MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 142 SIMPLIVIA: PRODUCTS OFFERED
  • TABLE 143 EQUASHIELD: PRODUCTS OFFERED
  • TABLE 144 BD: PRODUCT OFFERED
  • TABLE 145 BAXTER: PRODUCT OFFERED
  • TABLE 146 CORMED: PRODUCT OFFERED
  • TABLE 147 YUKON MEDICAL: PRODUCTS OFFERED
  • TABLE 148 YUKON MEDICAL: KEY DEVELOPMENTS
  • TABLE 149 CARAGEN LTD: PRODUCT OFFERED

LIST OF FIGURES

  • FIGURE 1 CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
  • FIGURE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; TYPE SEGMENT, (USD MILLION)
  • FIGURE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY TYPE,
  • FIGURE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; COMPONENT SEGMENT, (USD MILLION)
  • FIGURE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY COMPONENT,
  • FIGURE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; CLOSING MECHANISM SEGMENT, (USD MILLION)
  • FIGURE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY CLOSING MECHANISM,
  • FIGURE 15 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; TECHNOLOGY SEGMENT, (USD MILLION)
  • FIGURE 16 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY TECHNOLOGY,
  • FIGURE 18 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET; END USER SEGMENT, (USD MILLION)
  • FIGURE 19 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 20 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE (%), BY END USER,
  • FIGURE 21 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 EUROPE MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 31 ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 33 REST OF THE WORLD CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 34 REST OF THE WORLD CLOSED SYSTEM DRUG TRANSFER DEVICES MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 35 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 36 COMPETITOR DASHBOARD: GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
  • FIGURE 37 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 39 JMS CO.LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 ICU MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ICU MEDICAL, INC.: SWOT ANALYSIS
  • FIGURE 42 BD: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 BD: SWOT ANALYSIS
  • FIGURE 44 BAXTER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 BAXTER: SWOT ANALYSIS
  • FIGURE 46 YUKON MEDICAL: SWOT ANALYSIS